Pharma Archives - Page 6 of 79 - Life Sciences Times

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

September 19, 2025

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

September 15, 2025

THIS WEEK'S STORIES

Dr. Vince Clinical Research Begins Dosing in Phase 1b Trial of Enveda’s Investigational Drug ENV-294 for Atopic Dermatitis

September 16, 2025

Mevion Medical Systems Secures FDA Clearance for MEVION S250-FIT Proton Therapy System

September 15, 2025

Vertex Secures CASGEVY Reimbursement Agreement in Italy for Beta Thalassemia and Sickle Cell Disease

September 18, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

KalVista Wins EU, Swiss Approvals for EKTERLY, First Oral On-Demand Therapy for Hereditary Angioedema

Nuvation Bio Gains Japan Approval for IBTROZI in Advanced ROS1-Positive Lung Cancer

Deciphera Wins European Commission Approval for ROMVIMZA in Treating Tenosynovial Giant Cell Tumor

Rubedo Life Sciences Receives FDA Clearance for IND of RLS-1496 in Actinic Keratosis and Expands Clinical Advisory Board

Astria Therapeutics Announces Positive Phase 1a Results for STAR-0310, Supporting Potential Best-in-Class OX40 Antagonist

Most Read

MoldCo Raises $8 Million to Expand Mold Detox Platform and Tackle Widespread Health Crisis

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Boston Jury Awards $83 Million in Asbestos Verdict Against American Art Clay Company

Tanner Health, Healthliant Ventures Partner with Incision USA to Enhance Operating Room Performance

EDITOR PICKS

Blue Cross Blue Shield of Massachusetts Appoints Sophie Clarke as Chief Strategy Officer

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

THIS WEEK'S STORIES

Dr. Vince Clinical Research Begins Dosing in Phase 1b Trial of Enveda’s Investigational Drug ENV-294 for Atopic Dermatitis

Mevion Medical Systems Secures FDA Clearance for MEVION S250-FIT Proton Therapy System

Vertex Secures CASGEVY Reimbursement Agreement in Italy for Beta Thalassemia and Sickle Cell Disease

POPULAR CATEGORY

ABOUT US

FOLLOW US